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Conclusions. IMRT seems to be an ideal modality for tumours of the EAC/middle ear. However, further research is needed to
determine volumes, dose or suitability of the elective node irradiation.
http://dx.doi.org/10.1016/j.rpor.2013.03.381
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Introduction. The incidence of secondary cancers in paediatric patients is especially high, since children have a longer life
expectancy. There is evidence that Intensity Modulated Radiation Therapy (IMRT) increases the risk for developing secondary
malignancies, compared to conventional therapies (3D-CRT). Seven paediatric neuroblatoma patients were treated at our center
with Volumetric Modulated Arc Therapy (VMAT).
Objectives. This study evaluates dose distribution of VMAT to normal tissues proximal and distal to the PTV as compared to
3D-CRT and IMRT.
Method. A 3D-CRT and an IMRT ﬁve-ﬁeld plan were designed and compared to a VMAT plan. TPS Philips Pinnacle V9.0. Treatment
unit: Elekta Synergy linac. Two regions were deﬁned for estimation of dose distribution to normal tissues. The ﬁrst region covered
the entire body except for the PTV and the lower extremities. The second region was a 5-cm ring around the PTV. We calculated
the maximum dose (Dmax), mean dose (Dmean), and integral dose (ID) for both regions in the three plans. We also performed a
comparison of the number of monitor units (MU). Statistical analysis was performed using Friedman and Wilkinson tests with
the Bonferroni correction (p<0.017).
Results. Similar dose pattern values were obtained for both regions in the three plans. Dmax values were similar in all three
techniques. Dmean values were similar between IMRT and VMAT (p=0.043) and both lower than in 3D-CRT (p=0.018). There were
signiﬁcant differences in MUs with the lowest mean value found in the VMAT plan. ID was higher for 3DCRT (p=0.018), and
similar between IMRT and VMAT (p=0.043).
Conclusions. Dose distribution was similar in VMAT and IMRT. The Dmean dose was lower and MUs were higher in VMAT, compared
to 3D-CRT. The incidence of secondary cancers may be lower in VMAT-treated patients, as compared to IMRT-treated patients.
Nevertheless, these conclusions should be considered with caution, given the small sample size.
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Purpose. To evaluate retrospectively the efﬁcacy of low-dose radiotherapy in degenerative painful osteoarthritis.
Patients and methods. From January 2006 to December 2012, 63 degenerative osteoarthritis of the knee (40 p, 81.6%), shoulder (4
p, 8.2%), hip (2 p, 4.1%) or plantar heel spur (3 p, 6.1%) from 49 distinctive patients underwent low-dose radiotherapy for pain
control. Analyzed series included 40 women and 9 men, with a median age of 85 years (range 42–91 years). Painful status was
measured by visual analogue scale (VAS), with a median pre-treatment value of VAS=8 (range 4–10). A median radiotherapy dose
of 5Gy (range 3–6Gy) was delivered in 10 daily fractions of 50 cGy. In those patients with a post-treatment VAS of or above 6, a
second course of identical radiotherapy was proposed.
Results. Initial response was evaluated 4 weeks after the end of treatment, with a median VAS=4 (range 1–10). Twenty-ﬁve
painful sites underwent a second course of radiotherapy with identical dose and median time interval between two treatments
of 8 weeks (range 4–63 weeks). With a median follow-up of 11 months (range 1–97 months), median VAS at last visit was of 3
(range 0–8). Two patients (4.1%) reported VAS=0, 29 p (59.2%) VAS=1–3, 16 p (32.7%) VAS=4–7 and 2 p (4.1%) VAS=8–10. Daily
requirements of analgesics were removed or substantially reduced in 44p (89.8%). Subjective patient perception of response to
irradiation evaluated at time of last visit regarding to pre-treatment status was considered as “better” by 91.8% of patients. No
patients presented acute or late complications attributable to radiation treatment.
Conclusions. Low-dose radiotherapy is an effective alternative for treatment of degenerative painful osteoarthritis.
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